Medical Device Makers May Be Exempted From Packaging Rules

New Delhi : Licensed manufacturers of medical devices are likely to be exempted from the Legal Metrology (Packaged Commodities) Rules, 2011 that mandates that every package must bear the name, address, telephone number, email of persons or of office that can be contacted in case of consumer complaints.

The Department of Pharmaceuticals, which has reconstituted the National Medical Devices Promotion Council, will hold its first meeting on Wednesday. On the council’s agenda is discussion around “exemption of licensed manufacturers of medical devices from the Legal Metrology (Packaged Commodities) Rules, 2011”.

The reconstitution comes after the Department for Promotion of Industry & Internal Trade (DPIIT) under the Ministry of Commerce and Industry, which was heading the Council from its inception, decided to hand over the onus. The meeting will be attended by representatives of industry associations and government officials.

Rajiv Nath, forum coordinator, AiMeD said that patient safety should be paramount and the move of doing away with the packaging rules will only benefit importers.

“Many Importers have not been implementing the packaging rules and the provisions of the Legal Metrology Act & Consumers Protection Act as the enforcement mechanism has been weak on them while being stringent on Indian manufacturers. When manufactures export to the US , EU , Middle East we respect the laws of the land but the importers who don’t wish to be regulated seek exemption from application of these laws and rules under the garb of ease of doing business,” he said.

He said the department of consumer affairs and DoP need to enforce the law and rule book equitably and provide a level playing fieldand not get mislead by importers.

“Patient safety aspects under Drugs Act are complementary to consumer protection aspects of Legal Metrology Act,” he said

national medical devices promotion council ministry of commerce and industry licensed legal metrology act department of pharmaceuticals council aimed rajiv nath drugs act
  • Related Posts

    The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

    NEW DELHI: Medical technology innovation is entering a new phase, with advanced cardiac implants, incisionless brain surgery, blood-based cancer screening, smart insulin delivery and real-time kidney-function monitoring among the technologies…

    Three arrested after liquor bottles found at pharma firm

    Patna: Three people were arrested and sent to jail after a large quantity of liquor bottles was found at Cellulas Pharma Private Limited in Kankarbagh during a raid by the…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

    The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

    Three arrested after liquor bottles found at pharma firm

    Three arrested after liquor bottles found at pharma firm

    NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

    NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

    National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

    National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

    Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

    Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

    Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources

    Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources